Brainstorm Cell Therapeutics shares owned by Bogart Wealth
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Bogart Wealth
from 13F filings
Historical chart of Bogart Wealth investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Bogart Wealth consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Brainstorm Cell Therapeutics by Bogart Wealth
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $5 | 2 | 2.50 |
2024-09-30 | $8 | 34 | 0.24 |